Inger Westborg
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study.
Journal: Acta ophthalmologica
Published: August 22, 2024
Faricimab versus bevacizumab for neovascular age-related macular degeneration: Cost analysis based on real-world data from the Swedish Macula Registry.
Journal: Acta ophthalmologica
Published: June 20, 2024
What about the fellow eye in treatment of neovascular age-related macular degeneration? Analysis of data from the Swedish macula register.
Journal: Acta ophthalmologica
Published: June 14, 2021
Exploration of real-world outcomes and treatment patterns in patients treated with anti-vascular endothelial growth factors for neovascular age-related macular degeneration in Sweden.
Journal: Acta ophthalmologica
Published: January 19, 2021
Treatment of age-related macular degeneration after cataract surgery: a study from the Swedish National Cataract and Macula Registers.
Journal: Acta ophthalmologica
Published: January 24, 2020
Follow-Up After Cataract Surgery - Comparison of the Practice in Two Institutions with the Aim of Optimize the Routine.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: January 18, 2020
Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR).
Journal: Acta ophthalmologica
Published: February 25, 2019
Baseline visual acuity as a prognostic factor for visual outcomes in patients treated with aflibercept for wet age-related macular degeneration: data from the INSIGHT study using the Swedish Macula Register.
Journal: Acta ophthalmologica
Published: March 20, 2018
Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration.
Journal: Ophthalmic epidemiology
Published: November 14, 2017
Treatment for neovascular age-related macular degeneration in Sweden: outcomes at seven years in the Swedish Macula Register.
Journal: Acta ophthalmologica
Published: February 14, 2017
RISK FOR LOW VISUAL ACUITY AFTER 1 AND 2 YEARS OF TREATMENT WITH RANIBIZUMAB OR BEVACIZUMAB FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Journal: Retina (Philadelphia, Pa.)
Published: February 01, 2017
Last Updated: 09/26/2026